Markets

Commodities

Currencies

Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care

Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion

loader